Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Neurosci Lett ; 504(3): 219-22, 2011 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-21964388

RESUMEN

Clinical studies indicate an increased incidence of impaired glucose tolerance in individuals with Parkinson's disease (PD). The mechanisms that underlie this co-morbidity are currently unknown. The purpose of this study was to analyze peripheral glucose tolerance following severe unilateral nigrostriatal dopamine (DA) depletion, and to determine whether central and peripheral insulin signaling was affected in the 6-hydroxydopamine (6-OHDA) middle-aged rat model of PD. Although serum insulin levels differed significantly between the 6-OHDA and sham groups over the course of a glucose tolerance test six weeks post-lesion, no significant effect on glucose tolerance or insulin signaling in skeletal muscle was observed. In contrast, markers of striatal insulin resistance were evident in the rats. These data suggest that while 6-OHDA may affect serum insulin levels and striatal insulin signaling, the unilateral 6-OHDA lesion model does not induce glucose intolerance or peripheral insulin resistance, at least at the six-week post-lesion timepoint.


Asunto(s)
Envejecimiento/metabolismo , Cuerpo Estriado/fisiopatología , Dopamina/fisiología , Intolerancia a la Glucosa/inducido químicamente , Insulina/fisiología , Trastornos Parkinsonianos/metabolismo , Sustancia Negra/fisiopatología , Animales , Antagonistas de Dopamina/toxicidad , Ingestión de Alimentos , Intolerancia a la Glucosa/metabolismo , Intolerancia a la Glucosa/fisiopatología , Prueba de Tolerancia a la Glucosa , Hipotálamo/metabolismo , Insulina/sangre , Insulina/farmacología , Resistencia a la Insulina , Masculino , Músculo Esquelético/efectos de los fármacos , Músculo Esquelético/metabolismo , Norepinefrina/metabolismo , Oxidopamina/toxicidad , Trastornos Parkinsonianos/inducido químicamente , Trastornos Parkinsonianos/fisiopatología , Ratas , Ratas Endogámicas F344
2.
Exp Neurol ; 231(1): 171-80, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21703262

RESUMEN

Clinical studies have indicated a link between Parkinson's disease (PD) and Type 2 Diabetes. Although preclinical studies have examined the effect of high-fat feeding on dopamine function in brain reward pathways, the effect of diet on neurotransmission in the nigrostriatal pathway, which is affected in PD and parkinsonism, is less clear. We hypothesized that a high-fat diet, which models early-stage Type 2 Diabetes, would disrupt nigrostriatal dopamine function in young adult Fischer 344 rats. Rats were fed a high fat diet (60% calories from fat) or a normal chow diet for 12 weeks. High fat-fed animals were insulin resistant compared to chow-fed controls. Potassium-evoked dopamine release and dopamine clearance were measured in the striatum using in vivo electrochemistry. Dopamine release was attenuated and dopamine clearance was diminished in the high-fat diet group compared to chow-fed rats. Magnetic resonance imaging indicated increased iron deposition in the substantia nigra of the high fat group. This finding was supported by alterations in the expression of several proteins involved in iron metabolism in the substantia nigra in this group compared to chow-fed animals. The diet-induced systemic and basal ganglia-specific changes may play a role in the observed impairment of nigrostriatal dopamine function.


Asunto(s)
Cuerpo Estriado/fisiopatología , Complicaciones de la Diabetes/metabolismo , Dopamina/fisiología , Resistencia a la Insulina/fisiología , Enfermedad de Parkinson/metabolismo , Sustancia Negra/metabolismo , Animales , Cuerpo Estriado/metabolismo , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/metabolismo , Grasas de la Dieta/efectos adversos , Grasas de la Dieta/metabolismo , Modelos Animales de Enfermedad , Dopamina/metabolismo , Hierro/metabolismo , Trastornos del Metabolismo del Hierro/complicaciones , Trastornos del Metabolismo del Hierro/metabolismo , Masculino , Vías Nerviosas/metabolismo , Enfermedad de Parkinson/etiología , Ratas , Ratas Endogámicas F344 , Sustancia Negra/patología
3.
Brain Res ; 1240: 185-95, 2008 Nov 13.
Artículo en Inglés | MEDLINE | ID: mdl-18805403

RESUMEN

Clinical evidence has shown a correlation between Parkinson's disease (PD) and Type 2 Diabetes (T2D), as abnormal glucose tolerance has been reported in >50% of PD patients. The development of insulin resistance and the degeneration of nigrostriatal dopamine (DA) neurons are both mediated by oxidative mechanisms, and oxidative stress is likely a mechanistic link between these pathologies. Although glucose uptake in neuronal tissues is primarily non-insulin dependent, proteins involved in insulin signaling, such as insulin receptor substrate 2 (IRS2) and glucose transporter 4 (GLUT4), are present in the basal ganglia. The purpose of this study was to determine whether nigrostriatal DA depletion affects measures of insulin resistance in the striatum. Six weeks after 6-hydroxydopamine (6-OHDA) infusion into the medial forebrain bundle, rats were classified as having either partial (20-65%) or severe (90-99%) striatal DA depletion. Increased IRS2 serine phosphorylation, a marker of insulin resistance, was observed in the DA-depleted striatum. Additionally, severe depletion resulted in decreased total IRS2, indicating possible degradation of the protein. Decreased phosphorylation of AKT and expression of the kinase glycogen synthase kinase-3 alpha (GSK3-alpha) was also measured in the striatum of severely DA-depleted animals. Finally, expression of heat shock protein 25 (Hsp25), which is protective against oxidative damage and can decrease stress kinase activity, was decreased in the striatum of lesioned rats. Together, these results support the hypothesis that nigrostriatal DA depletion impairs insulin signaling in the basal ganglia.


Asunto(s)
Ganglios Basales/metabolismo , Resistencia a la Insulina/fisiología , Trastornos Parkinsonianos/metabolismo , Adrenérgicos/toxicidad , Animales , Ganglios Basales/fisiopatología , Western Blotting , Cromatografía Líquida de Alta Presión , Glucógeno Sintasa Quinasa 3/metabolismo , Proteínas de Choque Térmico HSP27/metabolismo , Proteínas Sustrato del Receptor de Insulina/metabolismo , Masculino , Oxidopamina/toxicidad , Trastornos Parkinsonianos/complicaciones , Trastornos Parkinsonianos/fisiopatología , Fosforilación , Proteínas Proto-Oncogénicas c-akt/metabolismo , Ratas , Ratas Endogámicas F344 , Serina/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...